Dual antiplatelet treatment after stenting: is longer better?
Extension of DAPT might mitigate risk of stent thrombosis or subsequent thrombotic events elsewhere in the circulation. However, it will also increase bleeding risk and costs. Therefore, a key question that remained to be addressed by adequately powered clinical trials is whether or not extension of...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2014-11, Vol.384 (9954), p.1553-1555 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1555 |
|---|---|
| container_issue | 9954 |
| container_start_page | 1553 |
| container_title | The Lancet (British edition) |
| container_volume | 384 |
| creator | Sibbing, Dirk Massberg, Steffen |
| description | Extension of DAPT might mitigate risk of stent thrombosis or subsequent thrombotic events elsewhere in the circulation. However, it will also increase bleeding risk and costs. Therefore, a key question that remained to be addressed by adequately powered clinical trials is whether or not extension of DAPT beyond 1 year after PCI provides any net clinical benefit. |
| doi_str_mv | 10.1016/S0140-6736(14)60768-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629969608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0140673614607686</els_id><sourcerecordid>3476981551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-2df6fe4c2e55644ca5a5932fe9b9fc33e90ea710d7a2c1576741af40957dc76e3</originalsourceid><addsrcrecordid>eNqFkFtLHDEYQINYdL38hJYBX9aHsV9mcpkIKuKlFYQ-VMG3kM18I7HZmTXJFPz3ZnetBV98SkhOTpJDyFcKRxSo-P4bKINSyFpMKTsUIEVTig0yoUyykjP5sEkm78g22YnxCQCYAL5FtisOtVSKTsjJ5Wh8YfrkFt4k9JiKFNCkOfapMF3CUMSU565_PC5cLPzQP-a1Gaa8dbZHvnTGR9x_G3fJ_fXV3cXP8vbXj5uL89vSctqksmo70SGzFXIuGLOGG67qqkM1U52ta1SARlJopaks5VJIRk3HQHHZWimw3iXTtXcRhucRY9JzFy16b3ocxqipqJQSSkCT0YMP6NMwhj6_LlO0UdCArDPF15QNQ4wBO70Ibm7Ci6agl331qq9extOU6VVfLfK5b2_2cTbH9v3Uv6AZOFsDmHP8dRh0tA57i60LaJNuB_fpFacfDNa73lnj_-ALxv-_0bHSsJYsHZStDKJ-BU3Kncw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1618908073</pqid></control><display><type>article</type><title>Dual antiplatelet treatment after stenting: is longer better?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Sibbing, Dirk ; Massberg, Steffen</creator><creatorcontrib>Sibbing, Dirk ; Massberg, Steffen</creatorcontrib><description>Extension of DAPT might mitigate risk of stent thrombosis or subsequent thrombotic events elsewhere in the circulation. However, it will also increase bleeding risk and costs. Therefore, a key question that remained to be addressed by adequately powered clinical trials is whether or not extension of DAPT beyond 1 year after PCI provides any net clinical benefit.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(14)60768-6</identifier><identifier>PMID: 25037991</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute coronary syndromes ; Blood platelets ; Cardiovascular disease ; Clinical trials ; Coronary Artery Disease - therapy ; Coronary vessels ; Drug therapy ; Drug-Eluting Stents ; Female ; Humans ; Internal Medicine ; Male ; Mortality ; Patients ; Platelet Aggregation Inhibitors - administration & dosage ; Risk reduction ; Stents ; Thromboembolism ; Thrombosis</subject><ispartof>The Lancet (British edition), 2014-11, Vol.384 (9954), p.1553-1555</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Nov 1, 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-2df6fe4c2e55644ca5a5932fe9b9fc33e90ea710d7a2c1576741af40957dc76e3</citedby><cites>FETCH-LOGICAL-c518t-2df6fe4c2e55644ca5a5932fe9b9fc33e90ea710d7a2c1576741af40957dc76e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673614607686$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25037991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sibbing, Dirk</creatorcontrib><creatorcontrib>Massberg, Steffen</creatorcontrib><title>Dual antiplatelet treatment after stenting: is longer better?</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Extension of DAPT might mitigate risk of stent thrombosis or subsequent thrombotic events elsewhere in the circulation. However, it will also increase bleeding risk and costs. Therefore, a key question that remained to be addressed by adequately powered clinical trials is whether or not extension of DAPT beyond 1 year after PCI provides any net clinical benefit.</description><subject>Acute coronary syndromes</subject><subject>Blood platelets</subject><subject>Cardiovascular disease</subject><subject>Clinical trials</subject><subject>Coronary Artery Disease - therapy</subject><subject>Coronary vessels</subject><subject>Drug therapy</subject><subject>Drug-Eluting Stents</subject><subject>Female</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Mortality</subject><subject>Patients</subject><subject>Platelet Aggregation Inhibitors - administration & dosage</subject><subject>Risk reduction</subject><subject>Stents</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkFtLHDEYQINYdL38hJYBX9aHsV9mcpkIKuKlFYQ-VMG3kM18I7HZmTXJFPz3ZnetBV98SkhOTpJDyFcKRxSo-P4bKINSyFpMKTsUIEVTig0yoUyykjP5sEkm78g22YnxCQCYAL5FtisOtVSKTsjJ5Wh8YfrkFt4k9JiKFNCkOfapMF3CUMSU565_PC5cLPzQP-a1Gaa8dbZHvnTGR9x_G3fJ_fXV3cXP8vbXj5uL89vSctqksmo70SGzFXIuGLOGG67qqkM1U52ta1SARlJopaks5VJIRk3HQHHZWimw3iXTtXcRhucRY9JzFy16b3ocxqipqJQSSkCT0YMP6NMwhj6_LlO0UdCArDPF15QNQ4wBO70Ibm7Ci6agl331qq9extOU6VVfLfK5b2_2cTbH9v3Uv6AZOFsDmHP8dRh0tA57i60LaJNuB_fpFacfDNa73lnj_-ALxv-_0bHSsJYsHZStDKJ-BU3Kncw</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Sibbing, Dirk</creator><creator>Massberg, Steffen</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20141101</creationdate><title>Dual antiplatelet treatment after stenting: is longer better?</title><author>Sibbing, Dirk ; Massberg, Steffen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-2df6fe4c2e55644ca5a5932fe9b9fc33e90ea710d7a2c1576741af40957dc76e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Acute coronary syndromes</topic><topic>Blood platelets</topic><topic>Cardiovascular disease</topic><topic>Clinical trials</topic><topic>Coronary Artery Disease - therapy</topic><topic>Coronary vessels</topic><topic>Drug therapy</topic><topic>Drug-Eluting Stents</topic><topic>Female</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Mortality</topic><topic>Patients</topic><topic>Platelet Aggregation Inhibitors - administration & dosage</topic><topic>Risk reduction</topic><topic>Stents</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sibbing, Dirk</creatorcontrib><creatorcontrib>Massberg, Steffen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sibbing, Dirk</au><au>Massberg, Steffen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dual antiplatelet treatment after stenting: is longer better?</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>384</volume><issue>9954</issue><spage>1553</spage><epage>1555</epage><pages>1553-1555</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Extension of DAPT might mitigate risk of stent thrombosis or subsequent thrombotic events elsewhere in the circulation. However, it will also increase bleeding risk and costs. Therefore, a key question that remained to be addressed by adequately powered clinical trials is whether or not extension of DAPT beyond 1 year after PCI provides any net clinical benefit.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25037991</pmid><doi>10.1016/S0140-6736(14)60768-6</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2014-11, Vol.384 (9954), p.1553-1555 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1629969608 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Acute coronary syndromes Blood platelets Cardiovascular disease Clinical trials Coronary Artery Disease - therapy Coronary vessels Drug therapy Drug-Eluting Stents Female Humans Internal Medicine Male Mortality Patients Platelet Aggregation Inhibitors - administration & dosage Risk reduction Stents Thromboembolism Thrombosis |
| title | Dual antiplatelet treatment after stenting: is longer better? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T10%3A15%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dual%20antiplatelet%20treatment%20after%20stenting:%20is%20longer%20better?&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Sibbing,%20Dirk&rft.date=2014-11-01&rft.volume=384&rft.issue=9954&rft.spage=1553&rft.epage=1555&rft.pages=1553-1555&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(14)60768-6&rft_dat=%3Cproquest_cross%3E3476981551%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1618908073&rft_id=info:pmid/25037991&rft_els_id=1_s2_0_S0140673614607686&rfr_iscdi=true |